It is worth noting that the inhibition of AMPK is also observed, in the absence of ERα, in breast cancer cells harboring a mutant p53 protein, indicating ERα and mutant p53 proteins competitively inhibit AMPK phosphorylation [59]. This evidence concerns the gene PRKAA2 and breast carcinoma.